Donald Bodenner

Sourced from institutional research profiles (UAMS TRI or ARA).

High Impact

Role not yet determined

UAMS primary UA Little Rock University of Arkansas

Also affiliated: National Institutes of Health (1991–1995); Strong Memorial Hospital (1993); University of Arkansas Medical Center (2010–2019); University of Rochester Medicine (1995); National Institute of Diabetes and Digestive and Kidney Diseases (1991–1993); Central Arkansas Veterans Healthcare System (2001–2010); Iowa City VA Medical Center (1993); University of Rochester (1995)

30 h-index 91 pubs 4,074 cited

Research Areas

Biomedical Subjects

Links

Lab Website Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Donald Bodenner's research focuses on the treatment of advanced thyroid cancer, particularly radioiodine-refractory differentiated thyroid cancer and medullary thyroid cancer. He has investigated the efficacy of multitargeted tyrosine kinase inhibitors, such as lenvatinib (E7080), in clinical trials. His work has also explored the mechanisms of drug toxicity and protection, including the effects of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity and toxicity in specific organs.

Bodenner's publications also include work on the functional analysis of thyroid hormone inhibitory elements in the human thyrotropin beta-subunit gene and the management of postoperative hypoparathyroidism. His scholarship metrics include an h-index of 30, with 91 total publications and over 4,000 citations, designating him as a highly cited researcher. He leads a research group and maintains an active lab website.

Metrics

h-index: 30
Publications: 91
Citations: 4,074

Selected Publications

Effect of 0.8 g/kg/d vs 1.6 g/kg/d Protein Intake in a Traditional or Time-Restricted Eating Pattern on Whole-Body Protein Turnover and Myofibrillar Protein Breakdown (2026)

Current Developments in Nutrition DOI OpenAlex
Four-dimensional computed tomography and ultrasonography for prediction of pathological parathyroid location: a retrospective review of a single surgeon’s patients at a single institution (2024)

Gland Surgery 5 citations DOI OpenAlex
Relationship of Vitamin D Deficiency and Intraoperative Parathyroid Hormone Elevation in Completion and Total Thyroidectomy (2019)

Otolaryngology 2 citations DOI OpenAlex
Breast cancer prevention in older women: an algorithm to choose an optimal preventive agent (2019)

Breast Cancer Targets and Therapy 3 citations DOI OpenAlex
Ultrasound-assisted definition of inferior border of the trapezius muscle in lower trapezius island flap reconstruction (2019)

European Journal of Plastic Surgery 3 citations DOI OpenAlex
AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons (2018)

Head & Neck 71 citations DOI OpenAlex
Structural alterations in tumor‐draining lymph nodes before papillary thyroid carcinoma metastasis (2017)

Head & Neck 10 citations DOI OpenAlex
Ultrasound (2016)

DOI OpenAlex
Response to Sumer and Colleagues (2016)

Journal of the American Geriatrics Society DOI OpenAlex
Medical and Surgical Treatment of Parathyroid Diseases (2016)

7 citations DOI OpenAlex
Minimally Invasive Radio-Guided Parathyroidectomy (2016)

VideoEndocrinology DOI OpenAlex
Postoperative Calcium Management in Same‐Day Discharge Thyroid and Parathyroid Surgery (2016)

Otolaryngology 23 citations DOI OpenAlex
How to Perform 4D CT for Parathyroid Localization (2015)

VideoEndocrinology 2 citations DOI OpenAlex
American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: Postoperative Hypoparathyroidism - Definitions and Management (2015)

Endocrine Practice 253 citations DOI OpenAlex
Comparison of Intraoperative versus Postoperative Parathyroid Hormone Levels to Predict Hypocalcemia Earlier after Total Thyroidectomy (2015)

Otolaryngology 55 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

Title A Randomised, Double Blind Study to Compare the Complete Remission Rate Fol AstraZeneca
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of E70 Eisai
Bifunctional Gene Regulation by Thyroid Hormone Receptor NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases
BODENNER FNDTN 30-006029 University of Arkansas Foundation
A Phase II, Open-label Study to Assess the Efficacy and Tolerability of ZD6474 (ZACTIMA) TM) 100 mg Monotherapy in Subjects with Locallly Advanced or AstraZeneca
Phase II, Multicenter, Open-Label, Single Arm Trial to Evaluate the safety and Ef Eisai
VERA001: Molecular Profiling Analysis of Indeterminate Thyroid Nodule Fine Needle Aspirates to Determine Patterns Predictive of Benign or Malignant Di Veracyte, Inc.
An International, Phase II, Randomized, Double-Blinded, Placebo-Controlled, Multi AstraZeneca